161 related articles for article (PubMed ID: 32089334)
21. The association of black race with receipt of hysterectomy and survival in low-risk endometrial cancer.
Taylor KN; Li A; Manuel M; Rimel BJ; Kim KH
Gynecol Oncol; 2023 Aug; 175():156-162. PubMed ID: 37390596
[TBL] [Abstract][Full Text] [Related]
22. Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapy.
Hochreiter A; Kelly JR; Young MR; Litkouhi B; Black JD; Stromberger C; Higgins S; Schwartz PE; Damast S
Int J Gynecol Cancer; 2020 Jan; 30(1):48-55. PubMed ID: 31722964
[TBL] [Abstract][Full Text] [Related]
23. Who benefits from chemoradiation in stage III-IVA endometrial cancer? An analysis of the National Cancer Data Base.
Lester-Coll NH; Park HS; Rutter CE; Corso CD; Young MR; Ratner ES; Litkouhi B; Decker RH; Yu JB; Damast S
Gynecol Oncol; 2016 Jul; 142(1):54-61. PubMed ID: 27151429
[TBL] [Abstract][Full Text] [Related]
24. The long-term survival of women with surgical stage II endometrioid type endometrial cancer.
Ayhan A; Taskiran C; Celik C; Yuce K
Gynecol Oncol; 2004 Apr; 93(1):9-13. PubMed ID: 15047207
[TBL] [Abstract][Full Text] [Related]
25. Association of Pelvic and Para-Aortic Lymphadenectomy With Survival in Stage I Endometrioid Endometrial Cancer: Matched Cohort Analyses From the National Cancer Database.
Seagle BL; Kocherginsky M; Shahabi S
JCO Clin Cancer Inform; 2017 Nov; 1():1-14. PubMed ID: 30657385
[TBL] [Abstract][Full Text] [Related]
26. [Survival, prognostic factors and modern tendencies in adjuvant treatment of diagnosed endometrial cancer patients with or without lymph node dissection].
Ivanov I
Akush Ginekol (Sofiia); 2009; 48 Suppl 1():3-11. PubMed ID: 20387272
[TBL] [Abstract][Full Text] [Related]
27. Survival implications of staging lymphadenectomy for non-endometrioid endometrial cancers.
Venigalla S; Chowdhry AK; Shalowitz DI
Gynecol Oncol; 2018 Jun; 149(3):531-538. PubMed ID: 29559170
[TBL] [Abstract][Full Text] [Related]
28. Surgical and oncologic outcomes of minimally invasive surgery for stage I high-grade endometrial cancer.
Nasioudis D; Heyward QD; Haggerty AF; Giuntoli Ii RL; Burger RA; Morgan MA; Ko EM; Latif NA
Surg Oncol; 2020 Sep; 34():7-12. PubMed ID: 32103792
[TBL] [Abstract][Full Text] [Related]
29. Prognosis of women with apparent stage I endometrial cancer who had supracervical hysterectomy.
Matsuo K; Machida H; Takiuchi T; Garcia-Sayre J; Yessaian AA; Roman LD
Gynecol Oncol; 2017 Apr; 145(1):41-49. PubMed ID: 28215841
[TBL] [Abstract][Full Text] [Related]
30. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
Secord AA; Havrilesky LJ; O'Malley DM; Bae-Jump V; Fleming ND; Broadwater G; Cohn DE; Gehrig PA
Gynecol Oncol; 2009 Sep; 114(3):442-7. PubMed ID: 19560193
[TBL] [Abstract][Full Text] [Related]
31. Lymphadenectomy in women with endometrial cancer: aspiration and reality from a radiation oncologist's point of view.
Foerster R; Kluck R; Arians N; Rieken S; Rief H; Adeberg S; Bostel T; Schlampp I; Debus J; Lindel K
Radiat Oncol; 2015 Jul; 10():147. PubMed ID: 26179059
[TBL] [Abstract][Full Text] [Related]
32. Lymphadenectomy and prognosis for elderly females with stage I endometrioid endometrial cancer.
Zhao L; Li L; Ye Y; Han X; Fu X; Yu Y; Luo J
Arch Gynecol Obstet; 2019 Sep; 300(3):683-691. PubMed ID: 31256231
[TBL] [Abstract][Full Text] [Related]
33. Radiation and hormonal therapy for primary treatment of stage I endometrial cancer and long-term survival.
Pyrzak A; Chen L; Kocherginsky M; Barber EL
Gynecol Oncol; 2020 Aug; 158(2):331-338. PubMed ID: 32553589
[TBL] [Abstract][Full Text] [Related]
34. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
35. Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis.
Kim TH; Kim HS; Kim TJ; Chang SJ; Kim DY; Ryu SY; Kim BG; Kim YT; Bae DS; Ryu HS; Nam JH
Gynecol Oncol; 2016 Jun; 141(3):440-446. PubMed ID: 27020700
[TBL] [Abstract][Full Text] [Related]
36. Survival Analysis of Cancer Patients With FIGO Stage IIIA Endometrial Cancer.
Lum MM; Belnap TW; Frandsen J; Brown AP; Sause WT; Soisson AP; Dodson MK; Werner T; Gaffney DK
Am J Clin Oncol; 2015 Jun; 38(3):283-8. PubMed ID: 23774072
[TBL] [Abstract][Full Text] [Related]
37. Radical vaginal hysterectomy with extraperitoneal pelvic lymphadenectomy in cervical cancer.
Savino L; Borruto F; Comparetto C; Massi GB
Eur J Gynaecol Oncol; 2001; 22(1):31-5. PubMed ID: 11321490
[TBL] [Abstract][Full Text] [Related]
38. Optimizing the management of stage II endometrial cancer: the role of radical hysterectomy and radiation.
Wright JD; Fiorelli J; Kansler AL; Burke WM; Schiff PB; Cohen CJ; Herzog TJ
Am J Obstet Gynecol; 2009 Apr; 200(4):419.e1-7. PubMed ID: 19136095
[TBL] [Abstract][Full Text] [Related]
39. FIGO stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival.
Bristow RE; Zahurak ML; Alexander CJ; Zellars RC; Montz FJ
Int J Gynecol Cancer; 2003; 13(5):664-72. PubMed ID: 14675352
[TBL] [Abstract][Full Text] [Related]
40. Three-Year Recurrence-Free Survival in Patients With a Very Low Risk of Endometrial Cancer Who Did Not Undergo Lymph Node Dissection (Tree Retro): A Korean Multicenter Study.
Kim M; Choi C; Kim K; Lim MC; Park JY; Hong JH; Lee M; Paek J; Seoung J; Lee S; Lee TS
Int J Gynecol Cancer; 2018 Jul; 28(6):1123-1129. PubMed ID: 29664841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
